Functional Cross-talk between Ras and Rho Pathways: A Ras-SPECIFIC GTPase-ACTIVATING PROTEIN (p120RasGAP) COMPETITIVELY INHIBITS THE RhoGAP ACTIVITY OF DELETED IN LIVER CANCER (DLC) TUMOR SUPPRESSOR BY MASKING THE CATALYTIC ARGININE FINGER

作者: Mamta Jaiswal , Radovan Dvorsky , Ehsan Amin , Sarah L. Risse , Eyad K. Fansa

DOI: 10.1074/JBC.M113.527655

关键词:

摘要: The three deleted in liver cancer genes (DLC1–3) encode Rho-specific GTPase-activating proteins (RhoGAPs). Their expression is frequently silenced a variety of cancers. RhoGAP activity, which required for full DLC-dependent tumor suppressor can be inhibited by the Src homology 3 (SH3) domain Ras-specific GAP (p120RasGAP). Here, we comprehensively investigated molecular mechanism underlying cross-talk between two distinct regulators small GTP-binding using structural and biochemical methods. We demonstrate that only SH3 p120 selectively inhibits activity all DLC isoforms as compared with large set other representative or proteins. Structural mutational analyses provide new insights into putative interaction mode DLC1 atypical does not follow classical PXXP-directed interaction. Hence, associates targeting catalytic arginine finger thus competitively very potently inhibiting activity. novel findings this study shed light on mechanisms inhibitory effects suggest functional Ras Rho at level regulatory

参考文章(80)
Katsuhisa Kawai, Minoru Kiyota, Junichi Seike, Yuko Deki, Hitoshi Yagisawa, START-GAP3/DLC3 is a GAP for RhoA and Cdc42 and is localized in focal adhesions regulating cell morphology Biochemical and Biophysical Research Communications. ,vol. 364, pp. 783- 789 ,(2007) , 10.1016/J.BBRC.2007.10.052
T. Y. Kim, D. Vigil, C. J. Der, R. L. Juliano, Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility Cancer and Metastasis Reviews. ,vol. 28, pp. 77- 83 ,(2009) , 10.1007/S10555-008-9167-2
Geoffrey J. Clark, Channing J. Der, Aberrant function of the Ras signal transduction pathway in human breast cancer Breast Cancer Research and Treatment. ,vol. 35, pp. 133- 144 ,(1995) , 10.1007/BF00694753
Patryk Moskwa, Marie-Hélène Paclet, Marie-Claire Dagher, Erzsébet Ligeti, Autoinhibition of p50 Rho GTPase-activating Protein (GAP) Is Released by Prenylated Small GTPases Journal of Biological Chemistry. ,vol. 280, pp. 6716- 6720 ,(2005) , 10.1074/JBC.M412563200
Erzsébet Ligeti, Stefan Welti, Klaus Scheffzek, Inhibition and termination of physiological responses by GTPase activating proteins. Physiological Reviews. ,vol. 92, pp. 237- 272 ,(2012) , 10.1152/PHYSREV.00045.2010
Judy Wai Ping Yam, Frankie Chi Fat Ko, Chung-Yiu Chan, Dong-Yan Jin, Irene Oi-Lin Ng, Interaction of Deleted in Liver Cancer 1 with Tensin2 in Caveolae and Implications in Tumor Suppression Cancer Research. ,vol. 66, pp. 8367- 8372 ,(2006) , 10.1158/0008-5472.CAN-05-2850
Patrik Erlmann, Simone Schmid, Florian A. Horenkamp, Matthias Geyer, Thomas G. Pomorski, Monilola A. Olayioye, DLC1 activation requires lipid interaction through a polybasic region preceding the RhoGAP domain. Molecular Biology of the Cell. ,vol. 20, pp. 4400- 4411 ,(2009) , 10.1091/MBC.E09-03-0247